Nocturia
Conditions
Brief summary
Aim of this study was to observe The study was adjusted in two parts: PART 1 is a crossectional study in which the prevalance, risk factors and etiology of nocturia among postmenopausal women is assessed. PART 2 is a cohort study observing the impact of 10 different hormonal substitution therapies on nocturia.
Interventions
OTHERQuestionnaire
All women fulfilled 3 questionairres * TANGO * ICIQ -N * Perceived Stress Scale
Sponsors
University Hospital, Ghent
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Women with postmenopausal symptoms (hot flushes, atrophy, ..) * All women were 'early' postmenopausal stages +1a,+1b or +1c as defined by the 'Stages of Reproductive Aging Workshop' (STRAW) criteria
Exclusion criteria
* Intake of HRT on the moment of inclusion * women with thyroid dysfunction * women using antihypertensive agents * women with a history of psychiatric or neurological disorders * women with a history of alcohol or drug addiction.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in nocturnal Frequency | 6 months after initiating therapy | Change from baseline in nocturnal voiding episodes assessed via nycturia and menopause questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in bother linked with nocturnal frequency | 6 months | Change in VAS scale of bother linked with nocturnal frequency |
Countries
Belgium
Contacts
Primary ContactKim Pauwaert
Backup ContactKarel Everaert
Outcome results
None listed